BWX Technologies (BWXT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Revenue increased 13% year-over-year in Q1 2025 to $682.3 million, driven by both Government and Commercial Operations.
Adjusted EBITDA rose 13% to $130 million, and non-GAAP EPS grew 20% to $0.91, supported by higher operating earnings and a lower tax rate.
Net income was $75.5 million, up from $68.5 million in Q1 2024.
Major contract wins included a $2.6 billion, 10-year DOE contract and selection for advanced nuclear and national security projects.
Announced and closed key acquisitions, including Aerojet Ordnance Tennessee and the pending Kinectrics deal, expanding advanced materials and nuclear services.
Financial highlights
Q1 2025 revenue was $682.3 million, up from $604 million in Q1 2024 (+13% year-over-year).
Adjusted EBITDA reached $130 million, up from $115 million in Q1 2024 (+13% year-over-year).
Non-GAAP EPS was $0.91, up from $0.76 in Q1 2024 (+20% year-over-year); diluted GAAP EPS was $0.82, up from $0.75.
Free cash flow for Q1 2025 was $17 million, up from $3 million in Q1 2024.
Backlog reached $4.88 billion, with 61% expected to be recognized by end of 2026.
Outlook and guidance
Reaffirmed full-year 2025 guidance: revenue ~$3.0 billion, adjusted EBITDA $550–$570 million, non-GAAP EPS $3.40–$3.55, and free cash flow $265–$285 million.
Government Operations revenue expected to grow mid-single digits; Commercial Operations revenue expected to grow ~50% (including Kinectrics acquisition).
Commercial Operations EBITDA margin guided to 14%-15%, with margin recovery expected in H2 2025.
Over half of full-year EPS expected in the second half of 2025.
Sufficient liquidity and borrowing capacity to meet requirements for the next 12 months and beyond.
Latest events from BWX Technologies
- 2026 outlook projects high-teens revenue growth and double-digit free cash flow, fueled by nuclear demand.BWXT
Investor presentation18 Mar 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor on April 30, 2026.BWXT
Proxy Filing18 Mar 2026 - Record 2025 growth and strong 2026 outlook driven by nuclear demand and major contract wins.BWXT
Q4 202523 Feb 2026 - Q2 2024 delivered double-digit growth and a higher EPS outlook amid strong industry demand.BWXT
Q2 20242 Feb 2026 - Q3 2024 delivered 14% revenue growth, higher EPS, and a major special materials acquisition.BWXT
Q3 202417 Jan 2026 - $525M acquisition expands nuclear and isotope services, boosting global reach and workforce.BWXT
M&A Announcement10 Jan 2026 - Record revenue, backlog, and free cash flow drive strong 2025 growth outlook.BWXT
Q4 20247 Jan 2026 - 2025 proxy covers director elections, say-on-pay, officer liability, and auditor ratification.BWXT
Proxy Filing1 Dec 2025 - Board recommends all proposals, highlights strong governance, pay-for-performance, and ESG focus.BWXT
Proxy Filing1 Dec 2025